swisschems semaglutide As demand for GLP-1 therapies grows, synthetic peptide versions of semaglutide are rapidly emerging. But manufacturing method matters: impurity profiles stability immunogenicity regulatory standards Takeaway: “Follow-on” GLP-1 SwissChems Review: INSIDE10 for 10%

References Sies, H., Mailloux, R

Mostra un'azione che inibisce la sintesi di melanina grazie alla sua azione competitiva con la L-DOPA nel suo legame con la tirosinasi durante la sintesi di melanina

386,387 Autophagy-inducing small molecules and natural compounds Additional autophagy-inducing agents include lithium, which induces autophagy via inhibition of inositol monophosphatase and reduces tau and amyloid- aggregation in AD models, 388 and SMER28, a small-molecule enhancer of rapamycin that promotes autophagy and reduces tau and -synuclein aggregation in AD and PD models

Purbey, P.K., Jayakumar, P.C., Deepalakshmi, P.D., Patole, M.S